(2018) A blood‐Mind‐barrier‐penetrating anti‐human transferrin receptor antibody fusion protein for neuronopathic mucopolysaccharidosis II. Mol TherBoth CRISPR‐Cas9‐ and iPSC‐dependent approaches supply unprecedented alternatives for that era of cellular models of LSDs. These can be employed with the identification of new pathways lin